BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8605154)

  • 1. Conformational studies of microcystin-LR using NMR spectroscopy and molecular dynamics calculations.
    Trogen GB; Annila A; Eriksson J; Kontteli M; Meriluoto J; Sethson I; Zdunek J; Edlund U
    Biochemistry; 1996 Mar; 35(10):3197-205. PubMed ID: 8605154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seco[D-Asp3]microcystin-RR and [D-Asp3,D-Glu(OMe)6]microcystin-RR, two new microcystins from a toxic water bloom of the cyanobacterium planktothrixrubescens.
    Grach-Pogrebinsky O; Sedmak B; Carmeli S
    J Nat Prod; 2004 Mar; 67(3):337-42. PubMed ID: 15043406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular structure of the cyanobacterial tumor-promoting microcystins.
    Rudolph-Böhner S; Mierke DF; Moroder L
    FEBS Lett; 1994 Aug; 349(3):319-23. PubMed ID: 8050589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High crustacean toxicity of microcystin congeners does not correlate with high protein phosphatase inhibitory activity.
    Blom JF; Jüttner F
    Toxicon; 2005 Sep; 46(4):465-70. PubMed ID: 16112701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of microcystin production in an Antarctic cyanobacterial mat community.
    Jungblut AD; Hoeger SJ; Mountfort D; Hitzfeld BC; Dietrich DR; Neilan BA
    Toxicon; 2006 Mar; 47(3):271-8. PubMed ID: 16386280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of nodularin. An inhibitor of serine/threonine-specific protein phosphatases.
    Annila A; Lehtimäki J; Mattila K; Eriksson JE; Sivonen K; Rantala TT; Drakenberg T
    J Biol Chem; 1996 Jul; 271(28):16695-702. PubMed ID: 8663277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms underlying he interaction of motuporin and microcystins with type-1 and type-2A protein phosphatases.
    Craig M; Luu HA; McCready TL; Williams D; Andersen RJ; Holmes CF
    Biochem Cell Biol; 1996; 74(4):569-78. PubMed ID: 8960363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial degradation of microcystins and nodularin.
    Imanishi S; Kato H; Mizuno M; Tsuji K; Harada K
    Chem Res Toxicol; 2005 Mar; 18(3):591-8. PubMed ID: 15777098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The solution NMR structure of a blue-green algae hepatotoxin, microcystin-RR--a comparison with the structure of microcystin-LR.
    Trogen GB; Edlund U; Larsson G; Sethson I
    Eur J Biochem; 1998 Dec; 258(2):301-12. PubMed ID: 9874194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of protein phosphatase-1 bound to motuporin and dihydromicrocystin-LA: elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins.
    Maynes JT; Luu HA; Cherney MM; Andersen RJ; Williams D; Holmes CF; James MN
    J Mol Biol; 2006 Feb; 356(1):111-20. PubMed ID: 16343532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of several protein phosphatases by a non-covalently interacting microcystin and a novel cyanobacterial peptide, nostocyclin.
    Hastie CJ; Borthwick EB; Morrison LF; Codd GA; Cohen PT
    Biochim Biophys Acta; 2005 Nov; 1726(2):187-93. PubMed ID: 16046071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of conformational equilibria in aplidine using selective excitation 2D NMR spectroscopy and molecular mechanics/dynamics calculations.
    Cárdenas F; Caba JM; Feliz M; Lloyd-Williams P; Giralt E
    J Org Chem; 2003 Dec; 68(25):9554-62. PubMed ID: 14656079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer modelling of the 3-dimensional structures of the cyanobacterial hepatotoxins microcystin-LR and nodularin.
    Lanaras T; Cook CM; Eriksson JE; Meriluoto JA; Hotokka M
    Toxicon; 1991; 29(7):901-6. PubMed ID: 1926190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vibrational circular dichroism and IR spectral analysis as a test of theoretical conformational modeling for a cyclic hexapeptide.
    Bour P; Kim J; Kapitan J; Hammer RP; Huang R; Wu L; Keiderling TA
    Chirality; 2008 Nov; 20(10):1104-19. PubMed ID: 18506832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a colorimetric protein phosphatase inhibition assay and enzyme linked immunosorbent assay for the study of microcystins and nodularins.
    An J; Carmichael WW
    Toxicon; 1994 Dec; 32(12):1495-507. PubMed ID: 7725318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution conformation of a cyclic neurokinin antagonist: a NMR and molecular dynamics study.
    Zhang M; Quinn TP; Wong TC
    Biopolymers; 1994 Sep; 34(9):1165-73. PubMed ID: 7948730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic contributions to the risk assessment of microcystin in the environment.
    Dittmann E; Börner T
    Toxicol Appl Pharmacol; 2005 Mar; 203(3):192-200. PubMed ID: 15737674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulations of peptides and proteins with a continuum electrostatic model based on screened Coulomb potentials.
    Hassan SA; Mehler EL; Zhang D; Weinstein H
    Proteins; 2003 Apr; 51(1):109-25. PubMed ID: 12596268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory studies of dissolved radiolabelled microcystin-LR in lake water.
    Hyenstrand P; Rohrlack T; Beattie KA; Metcalf JS; Codd GA; Christoffersen K
    Water Res; 2003 Aug; 37(14):3299-306. PubMed ID: 12834722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of hepatotoxic homologues of Microcystin using a combination of selective adsorption media.
    Kubo T; Hosoya K; Watabe Y; Tanaka N; Sano T; Kaya K
    J Sep Sci; 2004 Mar; 27(4):316-24. PubMed ID: 15334920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.